Article

HER-3 Expression and MEK Activation in Non-small Cell Lung Cancer

2020-08-26

Abstract excerpt

<title>Abstract</title> <p>BackgroundHER-3 has a role in pathogenesis and development of resistance to targeted therapies in non-small cell lung cancer (NSCLC). MethodsWe analysed tumour samples from 45 patients with adenocarcinoma of the lung. HER-3 and HER-2 expression was identified using immunohistochemistry as well as bioinformatic interrogation of The Cancer Genome Atlas (TGCA). ResultsHER-3 was highly expr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0bd53810-0c6a-5aa8-a52d-455641b63e80
DOI: 10.21203/rs.3.rs-59361/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

HER-3 Expression and MEK Activation in Non-small Cell Lung CancerDOI 10.21203/rs.3.rs-59361/v1Read

HER3 expression and MEK activation in non-small-cell lung carcinomaSemantic proximity Read

The Effect of HER3 Expression on Prognosis in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Real-World Study.Semantic proximity Read

Germline <i>ERBB3</i> mutation in familial non-small cell lung carcinoma: expanding ErbB’s role in oncogenesisSemantic proximity Read

Molecular Pathways: HER3 Targeted TherapySemantic proximity Read

HER3 Comes of Age: New Insights into Its Functions and Role in Signaling, Tumor Biology, and Cancer TherapySemantic proximity Read

Targeting HER proteins in cancer therapy and the role of the non-target HER3Semantic proximity Read

Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor.Semantic proximity Read

ETS transcription factor ELK3 in human cancers: An emerging therapeutic targetSemantic proximity Read

Overexpression of major CDKN3 transcripts is associated with poor survival in lung adenocarcinomaSemantic proximity Read

Advances in Targeting HER3 as an Anticancer TherapySemantic proximity Read

HER3: Toward the Prognostic Significance, Therapeutic Potential, Current Challenges, and Future Therapeutics in Different Types of CancerSemantic proximity Read

Transcriptional activation of cyclin D1 via HER2/HER3 contributes to cell survival and EGFR tyrosine kinase inhibitor resistance in non-small cell lung carcinomaSemantic proximity Read